Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00065728
Recruitment Status : Terminated (Management decision)
First Posted : August 1, 2003
Last Update Posted : September 16, 2013
Information provided by (Responsible Party):
Alcon Research

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2008
  Study Completion Date : October 2008
  Certification/Extension First Submitted : November 27, 2012